Page 6 - Evaluate Pharma News Today

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors because of government incentives, says Dr Mike Tubbs.

The life sciences industry is facing a significant slowdown due to patent expirations. Many organizations have not established a robust enough...

Does the upside outweigh the downside for this pharma giant?

Since the outbreak of the coronavirus, the Chinese healthcare industry has made further significant progress in terms of quality and its international profile. This has made the sector more attractive to investors too, Remo Krauer, Senior Portfolio Manager at Bellevue Asset Management, writes.

Cell and gene therapies are one of the most active areas of research and investment in the development of medicine. This article examines the...

Per a new Syneos report, 80% of oncologists believe cancer advertising helps them make more informed treatment decisions

Some healthcare services will never become obsolete.

Some healthcare services will never become obsolete.

Besides Omicron, the industry will focus on RNA-based drugs, AI programs, gene therapy trials, financing deals, regulatory issues, and synthetic biology challenges.

MELBOURNE, Australia and ST. GALLEN, Switzerland, Dec. 14, 2021 /PRNewswire/ — CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd–...